The primary cells market is a part of the larger cell culture market, which also includes cell lines and cell culture media. Primary cells offer several advantages over cell lines, as they more accurately represent the in vivo conditions and responses of cells in the human body. They are particularly valuable in pre-clinical research and drug testing, where the use of primary cells can help predict how drugs will behave in the human body more effectively.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
The global primary cells market is projected to reach USD 2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the forecast period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, government investments for cell-based research, and increasing cancer research.
primary cells market refers to the market for primary cells in the field of biotechnology and life sciences. Primary cells are cells that are directly isolated from living tissues and organs, and they retain their original physiological and genetic characteristics. These cells are used extensively in various research applications, drug discovery, and development, as well as in toxicology studies.
The primary cells market has seen steady growth over the years, driven by increasing research and development activities in the pharmaceutical and biotechnology industries. The demand for primary cells is also fueled by the rising need for personalized medicine and the development of targeted therapies. Furthermore, advancements in cell isolation and preservation technologies have facilitated the expansion of this market.
Browse full Report @ https://www.prnewswire.com/news-releases/primary-cells-market-worth-2-8-billion--marketsandmarkets-301870993.html
Primary Cells Market Dynamics:
Drivers:
- Increasing cancer research
- Advantages of primary human cells over cell lines
- Increasing demand for monoclonal antibodies
- Rapid growth in biotechnology and biopharmaceutical industries
- Growing focus on personalized medicine
- Government investments for cell-based research
Restraints:
- Concerns regarding primary cell culture contamination
- Ethical concerns regarding research in cell biology
Opportunities:
- Advancing biomedical research using primary cells in 3D cultures
Challenges:
- Sourcing and availability of primary cells
Key Market Players:
Key players in the primary cells market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), ProMab Biotechnologies, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix (Switzerland), ReachBio LLC (US), AcceGen (US), AMSBIO (UK), and Kosheeka (India).
North America is the largest regional market for primary cells.
The global primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the primary cells market. The increasing number of players launching new human primary cells for research, expansion in the pharmaceutical and biotechnology industries, rising incidences of cancer and various other chronic and infectious diseases, and the growing focus on R&D in the region are the major factors driving the growth of the North American market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com